Triple Negative Breast Cancer (TNBC) is a highly aggressive and clinically challenging form of breast cancer, characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. Due to the lack of these traditional biological targets, TNBC historically relied on chemotherapy. However, recent breakthroughs,... https://www.databridgemarketresearch.com/reports/global-triple-negative-breast-cancer-market